Amundi (ENXTPA:AMUN) Dropped, So What Is Behind The Latest Attention?
MAS mandate puts Amundi’s Asia ambitions in focus
Amundi (ENXTPA:AMUN) just picked up a fresh mandate from the Monetary Authority of Singapore, joining four peers in the latest round of its S$6.5b Equity Market Development Programme allocations.
The new MAS mandate lands after a softer patch for the Amundi share price, which is down 6.24% on a 30 day share price return and 2.87% on a 7 day share price return. However, year to date the share price return is up 23.46% and the 1 year total shareholder return is 34.58%, indicating longer term momentum that may reflect shifting views on its earnings resilience and capital return, including the recently completed €500m buyback covering 2.88% of shares.
Compare Amundi’s Asia push with other asset managers by scanning a curated group of list of solid balance sheet and fundamentals (207 results) that could also benefit from rising cross-border capital flows.
Amundi has taken a breather after a strong 1-year run, even as fresh MAS business and a completed €500m buyback reshape the equity story. Is most of the rerating already in the rear-view mirror, or is it not yet reflected in the price?
Most Popular Narrative: 8% Undervalued
Amundi’s most followed narrative pegs fair value at €95.55 using a 9.62% discount rate, which sits above the last close at €87.90 and frames the current price as leaving some room based on those assumptions.
The partnership with SBI in India and a direct presence in other Asian markets underscore an expected rise in revenues from increased market penetration and capturing growing client assets in these regions.
Strategic investments in fixed income platforms, which have generated notable inflows, suggest enhanced long-term revenue growth driven by demand for secure and attractive return solutions.
See why 22 investors see Amundi as 8% undervalued.
Result: Fair Value of €95.55 (UNDERVALUED)
Still, the proposed exceptional French tax and the exit from a €12b European insurance mandate could quickly challenge the current Amundi rerating story.
Find out about the key risks to this Amundi narrative.
Next Steps
If this Amundi story seems balanced between potential and pressure, consider acting quickly and assessing the trade-off for yourself by reviewing the 1 key reward and 1 important warning sign.
Looking for more Amundi-sized investment ideas?
Do not stop with Amundi. Broaden your watchlist using focused stock lists built from hard data so you keep spotting opportunities before they feel obvious to everyone else.
- Target potential mispricing by scanning companies that score well on quality and valuation through the 191 high quality undervalued stocks.
- Lock in income ideas by reviewing a hand picked pool of higher yield payers via the 168 dividend fortresses.
- Dial down portfolio stress by assessing financially resilient businesses filtered in the 226 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com